title: Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
abstract: The ability of 3-hydroxypyridin-4-ones (CP), a family of bidentate orally effective iron chelators, to remove iron and to prevent iron-induced lipid peroxidation was studied in beating rat myocardial cells in culture. The iron (III) binding constant (log beta 3) of all CP compounds is 36, but their lipophilicity may be modified by altering the length of the R2 substituent on the ring nitrogen. There was a direct relation between lipid solubility and chelating efficiency. Although at high concentrations all CP compounds were more effective in iron mobilization than deferoxamine, the opposite was true for low concentrations. Further studies with 1,2-diethyl-3-hydroxypyridin-4-one (CP94), the most effective CP compound, have shown that iron mobilization is completed within 6 hours, that effective mobilization requires a drug: iron molar ratio exceeding 3:1 permitting the formation of a hexadentate complex, and that the beneficial effects of iron mobilization are manifested in a marked reduction in membrane lipid peroxidation as indicated by cellular malonaldehyde content. Our study represents the first demonstration of a direct interaction between myocardial cells and an orally effective iron chelator, and underlines the need for high molar concentrations for achieving an optimal therapeutic effect.
authors.affiliation: Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.
authors.forename: C
authors.initials: C
authors.lastname: Hershko
authors.forename: G
authors.initials: G
authors.lastname: Link
authors.forename: A
authors.initials: A
authors.lastname: Pinson
authors.forename: H H
authors.initials: HH
authors.lastname: Peter
authors.forename: P
authors.initials: P
authors.lastname: Dobbin
authors.forename: R C
authors.initials: RC
authors.lastname: Hider
mesh_terms: D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D003676:Deferoxamine / Q000378:metabolism; D007501:Iron / Q000302:isolation & purification / Q000378:metabolism*; D007502:Iron Chelating Agents / Q000378:metabolism* / Q000494:pharmacology; D007700:Kinetics; D015227:Lipid Peroxidation / Q000187:drug effects; D008315:Malondialdehyde / Q000378:metabolism; D009206:Myocardium / Q000737:chemistry*; D011728:Pyridones / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats
chemical_list: D007502:Iron Chelating Agents; D011728:Pyridones; C020366:3-hydroxy-4-pyridone; C068543:1,2-diethyl-3-hydroxypyridin-4-one; D008315:Malondialdehyde; D007501:Iron; D003676:Deferoxamine